Gilead to buy cancer drugmaker Immunomedics in $21 billion deal – CNBC
Business News
- Gilead to buy cancer drugmaker Immunomedics in $21 billion deal CNBC
- Gilead Reaches Deal to Buy Immunomedics for $21 Billion The Wall Street Journal
- Gilead Nears $20 Billion Deal for Immunomedics, WSJ Says msnNOW
- Gilead nears deal to buy Immunomedics for more than $20 billion – WSJ Yahoo Finance
- Gilead to Buy Immunomedics in $21 Billion Deal for Cancer Drug Bloomberg
- View Full Coverage on Google News
Source: Business News